Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Immunotherapy in the view of microbiome.

Seminars in cancer biology·2026
Same author

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications.

Advanced drug delivery reviews·2026
Same author

Scaffolds toughen bacteria-based therapy.

Science (New York, N.Y.)·2026
Same author

Peptide-Based PROTACs: Transitioning from Static Paradigm to a Dynamic Landscape within Targeted Protein Degradation.

Bioconjugate chemistry·2026
Same author

Engineering platelets as cancer therapeutics.

Nature reviews. Clinical oncology·2026
Same author

Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery.

Proceedings of the National Academy of Sciences of the United States of America·2025

Related Experiment Video

Updated: Jul 19, 2025

In Vitro Assay to Study Tumor-macrophage Interaction
08:36

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

7.6K

Targeting Macrophages for Tumor Therapy.

Yixin Wang1,2,3, Allie Barrett1, Quanyin Hu4,5,6

  • 1Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, WI, I 53705, Madison, U.S.A.

The AAPS Journal
|August 17, 2023
PubMed
Summary

Macrophages are key in tumors, with M2 types promoting growth. Targeting these tumor-associated macrophages (TAMs) offers new cancer therapy strategies, including repolarization and biomimetic carriers.

Keywords:
cell engineeringdrug deliverymacrophagestumor therapy

More Related Videos

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.6K
Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
09:23

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

14.1K

Related Experiment Videos

Last Updated: Jul 19, 2025

In Vitro Assay to Study Tumor-macrophage Interaction
08:36

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

7.6K
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.6K
Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
09:23

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

14.1K

Area of Science:

  • Immunology
  • Oncology
  • Biomedical Engineering

Background:

  • Macrophages are abundant in tumors and influence progression.
  • Tumor-associated macrophages (TAMs) polarization (M1 vs. M2) impacts metastasis and treatment resistance.
  • M2 macrophages promote tumor growth and immune evasion, while M1 macrophages can attack tumor cells.

Purpose of the Study:

  • To review the role of macrophages in tumor development and metastasis.
  • To summarize recent advances in macrophage-centered anticancer therapies.
  • To discuss challenges and future applications of targeting macrophages in oncology.

Main Methods:

  • Review of literature on macrophage biology in cancer.
  • Analysis of therapeutic strategies targeting tumor-associated macrophages.
  • Exploration of biomimetic carriers and CAR-macrophage engineering.

Main Results:

  • TAMs significantly influence tumor progression, metastasis, and therapeutic outcomes.
  • Strategies like TAM repolarization, depletion, and signaling blockade show therapeutic promise.
  • Macrophage-based biomimetic carriers enhance drug delivery and reduce immunogenicity.
  • Chimeric antigen receptor (CAR)-engineered macrophages offer targeted tumor cell phagocytosis.

Conclusions:

  • Modulating the tumor immune microenvironment by targeting macrophages can overcome immunosuppression and enhance anti-tumor responses.
  • Macrophage-centered therapies hold potential for treating solid, drug-resistant, and metastatic tumors.
  • Further research into macrophage-based strategies will expand cancer treatment options.